CPLD 2006 FFSE vs Respondent M31

Facts
The French Federation for Company Sport (Fédération Française du Sport d'Entreprise, FFSE) charges respondent M31 for a violation of the Anti-Doping rules. During an athletics event on June 18, 2005, a sample was taken for doping test purposes. The analysis of the sample showed the presence of a metabolite of budesonide which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The disciplinary committee of the FFSE had delivered a warning in her decision on November 7, 2005.

The respondent had used a pharmaceutical product on the day of the coping control containing the prohibited substance. He uses medication to treat his asthma and has documents that proof his condition and his need for medication.

Decision
1. The decision of the disciplinary committee will not be changed.
2. The present decision will not be published.
3. The decision will be sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
27 April 2006
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Reprimand / warning
Sport/IFs
Athletics (WA) - World Athletics
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Conseil de Prévention et de Lutte contre le Dopage (CPLD) - Council to Prevent and Counteract Doping
Fédération Française du Sport d'Entreprise (FFSE) - French Federation for Company Sport
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S9. Glucocorticosteroids
Substances
Budesonide
Medical terms
Asthma
Treatment / self-medication
Document type
Pdf file
Date generated
1 October 2014
Date of last modification
2 October 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin